Sweetener of the Millennium
line decor
line decor
STEVIA NEWS AND ARTICLES

 

Stevia Price Increase

Starting from Q1 2014, the Stevia price has increased significantly by around 20%. According to sources from the growers’ side, the Stevia Rebaudianum cultivation in China has drastically declined over the past few years, which resulted in a price increase in the North American market.

GWI explains that by 2010, Chinese production exceeded global demand and the stevia farmer‘s profit margins were slim, so the cultivation area already began to decrease in 2011. The reason that a shortfall is just now predicted for 2014 is that the market has been working through reserves left from the 2010 and 2011 harvests. It is reported that growers haven‘t benefited a s much as expected from increased demand, yet some increase in cultivation area is planned for 2014.

Sources

1.   Green Wave Ingredients (GWI). The Stevia Paradox: story behind the sweet trend.

Published on Friday, May 09 2014: http://www.gwiusa.com/index.php/latestnews/108-stevia-paradox-story-behind-market-trend

 

2.   Penner R, Shanks T, Timcke A., et al. Stevia from Paraguay. Asuncion, Paraguay: USAID. September 2004: http://pdf.usaid.gov/pdf_docs/PNADB003.pdf

 

France first in Europe to anticipate Stevia approval

Food manufacturers in France are hoping to be the first in Europe to use the high-intensity stevia extract Rebaudioside-A (also known as Reb A and Rebiana), before the rest of continent receives full approval, reported Food Navigator USA. Read more..http://www.ausfoodnews.com.au/2009/06/02/france-first-in-europe-to-anticipate-stevia-approval.html

In December 2008:

The US Food and Drug Administration (US FDA) stated it had no objection to the conclusion of an expert panel that rebaudioside A is generally recognized as safe (GRAS) for use as a general purpose sweetener.  Prior to this, stevia-based ingredients were only permitted for use as a dietary supplement in the U.S. 

JECFA Conclusion: Stevia and stevioside are safe

The Joint Expert Committee on Food Additives (JECFA), an independent, international expert panel administered by the United Nations and World Health Organization, has conducted a thorough scientific review of all the available scientific data on steviol glycosides, including rebaudioside A (used in rebiana) and concluded that they are safe for their intended use - to sweeten foods and beverages and established a permanent Acceptable Daily Intake (ADI) level.  

Coca-Cola, Pepsi Launch Stevia-Sweetened Drinks

Cargill rolling out natural, no-calorie sweetener

Geneva 2005

The WHO Committee noted that stevioside has shown some evidence of pharmacological effects in patients with hypertension or with type-2 diabetes at doses corresponding to about 12.5–25mg/kgbw per day (equivalent to 5–10mg/kgbw per day expressed as steviol). The evidence available at present was inadequate to assess whether these pharmacological effects would also occur at lower levels of dietary exposure, which could lead to adverse effects in some individuals (e.g. those with hypotension or diabetes). The Committee therefore decided to allocate a temporary ADI, pending submission of further data on the pharmacological effects of steviol glycosides in humans.

World Health Organization Findings on Stevia: Evidence Shows Stevia Affects Patients With Hypertension and Type 2 Diabetes:

Stevia in Canada

According to Health Canada Sugar Substitutes section Purified stevia extract is regulated as a food additive in Canada. More....

 

ARTICLES ON STEVIA:

STEVIA REFERENCES AND RESEARCH STUDY

Stevia by Science Tech, Entrepreneur

Copyright 2008 | Site owned and operated by: EverStevia.com, All Rights Reserved. Toronto, Ontario, Canada.

Bookmark this site! | contact us | sitemap

Disclaimer: The information provided on EverStevia.com is for educational purposes only and IS NOT intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek professional medical advice from your physician or other qualified healthcare provider with any questions you may have regarding a medical condition.